HTRA2 Recombinant Antibody, Cy3 Conjugated
Product Specifications
Background
Serine protease that shows proteolytic activity against a non-specific substrate beta-casein. Promotes or induces cell death either by direct binding to and inhibition of BIRC proteins (also called inhibitor of apoptosis proteins, IAPs), leading to an increase in caspase activity, or by a BIRC inhibition-independent, caspase-independent and serine protease activity-dependent mechanism. Cleaves THAP5 and promotes its degradation during apoptosis. Isoform 2 seems to be proteolytically inactive.
Synonyms
HTRA2; HtrA-like serine protease; OMI; PARK13; Protease; PRSS25; Serine protease 25; HtrA serine peptidase 2; Serine proteinase OMI.
Gene ID
27429
Swiss Prot
O43464
Cellular Locus
Cytoplasm, Cell membrane
Host
Rabbit
Cross Reactivity
Human, Mouse, Rat
Target
HTRA2
Clonality
Recombinant
Isotype
IgG
Conjugation
Cy3
Source
KLH conjugated synthetic peptide derived from human HTRA2
Applications
WB, IF
Purification
Purified by Protein A.
Excitation Emission
512,550nm/570,615nm
Concentration
Lot dependent
Dilution
WB (1:300-5000), IF ()
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
27429
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
E45H20015-2 20 µg
FKBP12 (FKBP1A) (NM_000801) Human Over-expression Lysate
Sign In for Pricing
View Details 
128837-FITC 100 µL
KIR3DX1 (Putative Killer Cell Immunoglobulin-like Receptor-like Protein KIR3DX1, Leukocyte Receptor Cluster Member 12, KIR3DL0, LENG12, FLJ00060) (FITC)
Sign In for Pricing
View Details